2Ohe Y. Chemoradiotherapy for lung cancer [J]. Expert Opin Pharmacother, 2005,6 (16) :2793-2804.
3Schiller JH,Harrington D, Belani CP, et al. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer [J] N Engl J Med,2002,346(2) :92-98.
4Shepherd FA, Dancey J, Ramlau R, et al. Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum- based chemotherapy[J]. J Clin Oncol,2000,18(10) :2095-2103.
5Fossella FV, DeVore R, Kerr RN, et al. Randomized phase Ⅲ trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group [J]. J Clin Oncol, 2000,18(12) :2354-2362.
6Calvert H. An overview of folate metabolism: features relevant to the action and toxicities of antifolate anticancer agents[J]. Semin Oncol,1999,26(2 Suppl 6) :3-10.
7Adjei AA. Pharmacology and mechanism of action of pemetrexed[J]. Clin Lung Cancer, 2004,5 (Suppl 2) : S51-55.
8Hanna N, Shepherd FA, Fossella FV, et al. Randomized phase Ⅲ trial of pemetrexed versus docetaxel in patients with non- small cell lung cancer previously treated with chemotherapy[J]. J Clin Oncoi,2004,22(9) : 1589-1597.
6Wakelee H,Kernstine K,Vokes E,et al.Cooperative group research efforts in lung cancer 2008:focus on advanced-stage non-small-cell lung canacer[J].Clin Lung Cancer,2006,9(6):346-351.
7Brodowicz T,Krzakowski M,Zwitter M.Cisplatin and gemcitabine first-line chemotherapy follwed by maintenance gemcitabine or best supportive care in advanced non-small cell lung cancer:A phase III trial[J].Lung Cancer,2006,52(2):15-163.
8Asukai Y, Valladares A, Camps C, et al. Cost-effectiveness analysis of pemetrexed versus docetaxel in the second-line treatment of non- small cell lung cancer in Spain: results for the non-squamous histol- ogy population. BMC Cancer, 2010, 10: 26.
9National Cancer Institute SEER data. [2009-06-20]. Available at: http://seer. cancer. gov/statistics/.
10Novello S, Le Chevalier T. Chemotherapy for non-small-cell lung cancer. Part 1: Early-stage disease. Oncology (Williston Park), 2003, 17(3): 357-364.
